The Value of and Challenges for Cholera Vaccines in Africa

被引:11
|
作者
von Seidlein, Lorenz [1 ]
Jiddawi, Mohammad [2 ]
Grais, Rebecca F. [3 ]
Luquero, Francisco [3 ]
Lucas, Marcelino [4 ]
Deen, Jacqueline [1 ]
机构
[1] Menzies Sch Hlth Res, Casuarina, NT 0810, Australia
[2] Minist Hlth, Zanzibar, Tanzania
[3] Epicentre, Paris, France
[4] Minist Hlth, Maputo, Mozambique
来源
关键词
cholera; vaccine; OCV; Africa; review; VIBRIO-CHOLERAE; FIELD TRIAL; VACCINATION; LIVE; BANGLADESH; CLIMATE; COST; O1; CONSTRUCTION; CANDIDATE;
D O I
10.1093/infdis/jit194
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The 21st century saw a shift in the cholera burden from Asia to Africa. The risk factors for cholera outbreaks in Africa are incompletely understood, and the traditional emphasis on providing safe drinking water and improving sanitation and hygiene has proven remarkably insufficient to contain outbreaks. Current killed whole-cell oral cholera vaccines (OCVs) are safe and guarantee a high level of protection for several years. OCVs have been licensed for > 20 years, but their potential for preventing and control cholera outbreaks in Africa has not been realized. Although each item in the long list of technical reasons why cholera vaccination campaigns have been deferred is plausible, we believe that the biggest barrier is that populations affected by cholera outbreaks are underprivileged and lack a strong political voice. The evaluation and use of OCVs as a tool for cholera control will require a new, more compassionate, less risk-averse generation of decision makers.
引用
收藏
页码:S8 / S14
页数:7
相关论文
共 50 条
  • [41] Cholera vaccines for the developing world
    Lopez, Anna Lena
    Clemens, John D.
    Deen, Jacqueline
    Jodar, Luis
    HUMAN VACCINES, 2008, 4 (02): : 165 - 169
  • [42] NEW CHOLERA VACCINES - FOR WHOM
    STEFFEN, R
    LANCET, 1994, 344 (8932): : 1241 - 1242
  • [43] Oral vaccines for preventing cholera
    Sinclair, D.
    Abba, K.
    Zaman, K.
    Qadri, F.
    Graves, P. M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (03):
  • [44] MOLECULAR DESIGN OF CHOLERA VACCINES
    MANNING, PA
    VACCINE, 1992, 10 (14) : 1015 - 1021
  • [45] PREPARATION AND POTENCY TESTING OF CHOLERA AND CHOLERA EL TOR VACCINES
    PESIGAN, TP
    SUMPAICO, J
    SYCHANGCO, G
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 1967, 37 (05) : 816 - +
  • [46] Progress and Challenges in Using Oral Cholera Vaccines to Control Outbreaks: The Medecins Sans Frontieres Experience
    Ciglenecki, Iza
    Azman, Andrew S.
    Jamet, Christine
    Serafini, Micaela
    Luquero, Francisco J.
    Cabrol, Jean-Clement
    JOURNAL OF INFECTIOUS DISEASES, 2018, 218 : S165 - S166
  • [47] Cholera outbreaks in Africa
    不详
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2023, 101 (03) : 164 - 164
  • [48] The Cholera Crisis in Africa
    Bhattacharya, S.
    Black, R.
    Bourgeois, L.
    Clemens, J.
    Cravioto, A.
    Deen, J. L.
    Dougan, Gordon
    Glass, R.
    Grais, R. F.
    Greco, M.
    Gust, I.
    Holmgren, J.
    Kariuki, S.
    Lambert, P. -H.
    Liu, M. A.
    Longini, I.
    Nair, G. B.
    Norrby, R.
    Nossal, G. J. V.
    Ogra, P.
    Sansonetti, P.
    von Seidlein, L.
    Songane, F.
    Svennerholm, A. -M.
    Steele, D.
    Walker, R.
    SCIENCE, 2009, 324 (5929) : 885 - 885
  • [49] Cholera Outbreaks in Africa
    Mengel, Martin A.
    Delrieu, Isabelle
    Heyerdahl, Leonard
    Gessner, Bradford D.
    CHOLERA OUTBREAKS, 2014, 379 : 117 - 144
  • [50] Fair value accounting implementation challenges in South Africa
    Pandya, Anuradha
    van Zijl, Wayne
    Maroun, Warren
    JOURNAL OF ACCOUNTING IN EMERGING ECONOMIES, 2021, 11 (02) : 216 - 246